1687-9104

Advances in Hematology

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 180 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact180 DOIs
2

Add abstracts to 21 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact21 DOIs
3

Deposit reference lists for 12 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact12 DOIs

DOIs for this ISSN

Showing the top 5 of 405 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The Zebrafish as a Tool to Study Hematopoiesis, Human Blood… (10.1155/2012/425345)
Abstract References ORCID
75.00 9
2 The Effect of<i>Taraxacum officinale</i>Hydroalcoholic Extra… (10.1155/2012/653412)
Abstract ORCID
66.11 20
3 The Role of BCL2 Family of Apoptosis Regulator Proteins in A… (10.1155/2012/524308)
ORCID
56.68 184
4 Steroid-Refractory Acute GVHD: Predictors and Outcomes (10.1155/2011/601953)
ORCID
55.95 172
5 Pathogen Recognition and Activation of the Innate Immune Res… (10.1155/2012/159807)
ORCID
53.01 131
6 Hydrogen Peroxide in Inflammation: Messenger, Guide, and Ass… (10.1155/2012/541471)
ORCID
51.61 115
7 Crosstalk between Platelets and the Immune System: Old Syste… (10.1155/2012/384685)
ORCID
49.89 98
8 Drug-Induced Hematologic Syndromes (10.1155/2009/495863)
ORCID
48.24 84
9 <i>In Vitro</i>and<i>In Vivo</i>Antitumor Effect of Anti-CD3… (10.1155/2012/683065)
ORCID
47.71 80
10 The Genetic Architecture of Multiple Myeloma (10.1155/2014/864058)
ORCID
46.88 74
11 Iron Loading and Overloading due to Ineffective Erythropoies… (10.1155/2010/358283)
ORCID
46.58 72
12 MicroRNAs as Haematopoiesis Regulators (10.1155/2013/695754)
ORCID
45.65 66
13 Hodgkin's Lymphoma: A Review of Neurologic Complications (10.1155/2011/624578)
ORCID
43.31 53
14 Mutations in Epigenetic Modifiers in Myeloid Malignancies an… (10.1155/2012/469592)
ORCID
43.31 53
15 Iron Overload in Sickle Cell Disease (10.1155/2010/272940)
ORCID
43.11 52
16 Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and… (10.1155/2010/750643)
ORCID
43.11 52
17 Biological Activity of Lenalidomide and Its Underlying Thera… (10.1155/2012/842945)
ORCID
43.11 52
18 Molecular Action of Lenalidomide in Lymphocytes and Hematolo… (10.1155/2012/513702)
ORCID
42.90 51
19 Murine Models of B-Cell Lymphomas: Promising Tools for Desig… (10.1155/2012/701704)
ORCID
42.90 51
20 Treatment of Febrile Neutropenia and Prophylaxis in Hematolo… (10.1155/2014/986938)
ORCID
42.90 51
21 Clinical Application of Mesenchymal Stem Cells in the Treatm… (10.1155/2011/427863)
ORCID
42.03 47
22 Donor Specific Anti-HLA Antibody and Risk of Graft Failure i… (10.1155/2016/4025073)
ORCID
41.80 46
23 Neutrophil Reverse Migration Becomes Transparent with Zebraf… (10.1155/2012/398640)
ORCID
41.09 43
24 Clinical Features, Treatment, and Outcome of HIV-Associated… (10.1155/2012/910954)
ORCID
40.84 42
25 Hepcidin: A Critical Regulator of Iron Metabolism during Hyp… (10.1155/2011/510304)
ORCID
40.32 40
26 Crosstalk between Erythropoiesis and Iron Metabolism (10.1155/2010/317095)
Abstract ORCID
38.91 5
27 Iron Overload in Patients Undergoing Hematopoietic Stem Cell… (10.1155/2010/345756)
ORCID
38.91 35
28 Review on Haploidentical Hematopoietic Cell Transplantation… (10.1155/2016/5726132)
ORCID
38.60 34
29 Crosstalk between Iron Metabolism and Erythropoiesis (10.1155/2010/605435)
ORCID
37.28 30
30 Marrow Stromal Cell Infusion Rescues Hematopoiesis in Lethal… (10.1155/2012/142530)
ORCID
37.28 30
31 Clinical Scenarios for Discordant Anti-Xa (10.1155/2016/4054806)
ORCID
37.28 30
32 Recent Advances in the Pathobiology of Hodgkin's Lymphoma: P… (10.1155/2011/439456)
ORCID
36.93 29
33 Erythropoiesis and Iron Sulfur Cluster Biogenesis (10.1155/2010/329394)
ORCID
36.56 28
34 Myeloablative Conditioning with PBSC Grafts for T Cell-Reple… (10.1155/2016/9736564)
ORCID
36.56 28
35 CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis (10.1155/2009/634292)
ORCID
36.18 27
36 Drift-Diffusion Analysis of Neutrophil Migration during Infl… (10.1155/2012/792163)
ORCID
36.18 27
37 Sonoclot Signature Analysis in Patients with Liver Disease a… (10.1155/2013/237351)
Abstract
36.18 27
38 Influence of Oxidative Stress on Stored Platelets (10.1155/2016/4091461)
ORCID
36.18 27
39 Combined Bone Marrow and Kidney Transplantation for the Indu… (10.1155/2016/6471901)
ORCID
36.18 27
40 Flow Cytometric Detection of the Classical Hodgkin Lymphoma:… (10.1155/2011/387034)
ORCID
35.78 26
41 Molecular-Targeted Therapies for Hematologic Malignancies (10.1155/2012/606423)
Abstract References ORCID
35.78 2
42 Exploring Risk Factors for Follicular Lymphoma (10.1155/2012/626035)
ORCID
35.78 26
43 Clinical Usefulness of Haptoglobin Levels to Evaluate Hemoly… (10.1155/2011/389854)
ORCID
35.37 25
44 Comorbidities of Idiopathic Thrombocytopenic Purpura: A Popu… (10.1155/2009/963506)
ORCID
34.95 24
45 Hodgkin's Disease in Patients with HIV Infection (10.1155/2011/402682)
ORCID
34.95 24
46 AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Act… (10.1155/2012/485943)
ORCID
34.95 24
47 <i>In Vitro</i>Whole Blood Clot Lysis for Fibrinolytic Activ… (10.1155/2014/814684)
ORCID
34.95 24
48 Secondary Primary Malignancies in Multiple Myeloma: An Old N… (10.1155/2012/801495)
ORCID
34.51 23
49 Management of Adenovirus in Children after Allogeneic Hemato… (10.1155/2013/176418)
ORCID
34.51 23
50 Relative Susceptibilities of ABO Blood Groups to<i>Plasmodiu… (10.1155/2016/5368793)
ORCID
34.51 23